Recipients are University of California at Berkeley biochemist Jennifer Doudna and Emmanuelle Charpentier of France
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — American and French scientists have won the 2020 Nobel Prize in chemistry for their work developing the revolutionary gene-editing tool CRISPR-Cas9.
The award for University of California at Berkeley biochemist Jennifer Doudna and Emmanuelle Charpentier of France was announced Wednesday, The Washington Post reported.
“This year’s prize is about rewriting the code of life,” said Goran Hansson, secretary general of the Royal Swedish Academy of Sciences.
CRISPR-Cas9 — often described as molecular scissors — can locate and snip out specific sections of DNA and is being investigated as a cancer therapy and a cure for inherited diseases, The Post reported.
Gene Mutation Identified That Increases Lung Cancer Risk 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Relapse Rare After Appendiceal Adenocarcinoma Resection .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction 
